A randomized controlled trial of analogue pharmacogenomic testing feedback for psychotropic medications
Objective: To examine the impact of various presentations of pharmacogenomic testing results using a published, color-coded decision support tool (DST) format as a standard stimulus to list possible medications. Methods: Participants were randomly assigned to groups and asked to decide which psychot...
Saved in:
Main Authors: | John Young (Author), Aileen Jimenez (Author), Madeline Pruett (Author), Laken Hancock (Author), McCall Schruff (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders
by: Bose-Brill S, et al.
Published: (2017) -
Efficacy of personal pharmacogenomic testing as an educational tool in the pharmacy curriculum: A nonblinded, randomized controlled trial
by: Chloe Grace, et al.
Published: (2021) -
Impact of an Online Discussion Forum on Self-Guided Internet-Delivered Cognitive Behavioral Therapy for Public Safety Personnel: Randomized Trial
by: Hugh C McCall, et al.
Published: (2024) -
Pharmacogenomics in clinical trials: an overview
by: Rita Nogueiras-Álvarez
Published: (2023) -
Adoption of Pharmacogenomic Testing: A Marketing Perspective
by: Margarita-Ioanna Koufaki, et al.
Published: (2021)